University of Sherbrooke
Also known as: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Centre Hospitalier Dr Georges-L.-Dumont | Centre hospitalier universitaire de Sherbrooke | Centre Hospitalier Universitaire de Sherbrooke | CIUSSS-Estrie-CHUS hospital | Clinical Urology and Epidemiology Working Group | CRC-CHUS | CSSS-IUGS - CIUSSS de L'Estrie - CHUS - Université de Sherbrooke | Cynthia Gagnon | École de réadaptation, CRCHUS, Université de Sherbrooke | Estrie University Integrated Health and Social Services Center - University Hospital of Sherbrooke | Gilles Boire | Jean-Patrice Baillargeon | Mélanie Plourde | Patrice Perron | Research Centre on Aging - CIUSSS de l'Estrie - CHUS | Research Centre on Aging - CSSS-IUGS - CIUSSS de l'Estrie - CHUS | Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) | Research Centre on Aging CSSS-IUGS - CIUSSS de l'Estrie - CHUS | Sherbrooke university medical school | Universitaire de Sherbrooke | Université de Sherbrooke | Université de Sherbrooke and CIUSSS de l'Estrie - CHUS | U of Sherbrooke
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2000Last known activity
Jan 31, 2026
Timeline
1950s
- Jan 1, 1954
University of Sherbrooke— Founded
Drugs by trial phase (116 distinct, 102 trials)
Phase 4 (23 own, 0 via acquisition)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (48 own, 0 via acquisition)
Indications
Studied for
- Amenorrhea
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Bone Resorption
- Bronchopulmonary Dysplasia
- Calculi
- Candidiasis
- Cardiovascular Diseases
- Cerebral Infarction
- Colorectal Neoplasms
- Communicable Diseases
- Coronavirus Infections
- Cystic Fibrosis
- Diabetes, Gestational
- Diabetes Mellitus
- Enuresis
- Fibromyalgia
- Fibrosis
- Fragile X Syndrome
- Glaucoma
- Glaucoma, Open-Angle
- Glioblastoma
- Gonorrhea
- Heart Failure
- Heart Failure, Systolic
- Hematoma
- Hematoma, Subdural
- Hematoma, Subdural, Chronic
- Hyperlipoproteinemia Type I
- Hypersensitivity
- Hypertension
- Hypothyroidism
- Infections
- Ischemia
- Kidney Calculi
- Lymphoma
- Lymphoma, Non-Hodgkin
- Menorrhagia
- Muscular Dystrophies
- Myofascial Pain Syndromes
- Nasal Polyps
- Nasopharyngeal Neoplasms
- Nephrolithiasis
- Neuroblastoma
- Obstetric Labor, Premature
- Ocular Hypertension
- Osteoporosis
- Overweight
- Postoperative Pain
- Premature Birth
- Prostatic Neoplasms
- Shock
- Shock, Septic
- Stroke
- Syndrome
- Ureteral Calculi
- Ureterolithiasis
- Urinary Incontinence
- Urinary Incontinence, Stress
- Vaginal Discharge
- Vaginal Diseases
- Vaginitis
- Vaginosis, Bacterial
Recent trials (50)
- NCT07309614Lead sponsorPhase 3Jan 31, 2026
- NCT07122531Sponsor investigatorN/AAug 25, 2025
- NCT07122531Lead sponsorN/AAug 25, 2025
- NCT07122531OfficialN/AAug 25, 2025
- NCT07104266OfficialPhase 2Aug 4, 2025
- NCT07104266Sponsor investigatorPhase 2Aug 4, 2025
- NCT07104266Lead sponsorPhase 2Aug 4, 2025
- NCT06843148OfficialN/AApr 30, 2025
- NCT06843148Sponsor investigatorN/AApr 30, 2025
- NCT06843148Lead sponsorN/AApr 30, 2025
- NCT06843148CollaboratorN/AApr 30, 2025
- NCT06401317CollaboratorN/AFeb 1, 2025
- NCT06401317CollaboratorN/AFeb 1, 2025
- NCT06356883OfficialPhase 2Dec 31, 2024
- NCT06356883Lead sponsorPhase 2Dec 31, 2024
Details
- Founded
- Sherbrooke, CA Jan 1, 1954
- Last known activity
- Jan 31, 2026